×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by George Eric Davis

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselSep 19, 2014Option/RSU Exercise$21.5117,536377,19981,962Sep 23, 2014, 08:41 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselSep 19, 2014Sale$69.7517,5361,223,13664,426Sep 23, 2014, 08:41 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 30, 2014Gift$23.211804,17856,588Jun 05, 2014, 07:32 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselJun 03, 2014Disposition to Issuer$60.003,562213,72053,026Jun 05, 2014, 07:32 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 12, 2014Tax Payment (Shares)$57.441,09662,95456,768May 19, 2014, 06:27 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 12, 2014Tax Payment (Shares)$59.301,09664,99357,864May 14, 2014, 07:56 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 30, 2014Award/Grant$29.6970420,90261,360May 12, 2014, 04:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 08, 2014Tax Payment (Shares)$56.781,69696,29958,960May 12, 2014, 04:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselFeb 20, 2014Option/RSU Exercise$21.5120,000430,20080,656Feb 24, 2014, 06:51 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselFeb 20, 2014Sale$80.0020,0001,600,00060,656Feb 24, 2014, 06:51 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 14, 2013Option/RSU Exercise$21.5120,000430,20061,708May 15, 2013, 01:57 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 14, 2013Sale$70.3420,0001,406,80041,708May 15, 2013, 01:57 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 12, 2013Tax Payment (Shares)$67.681,09674,17744,298May 14, 2013, 02:00 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 13, 2013Sale$69.292,590179,45241,708May 14, 2013, 02:00 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 08, 2013Tax Payment (Shares)$65.321,664108,69245,394May 10, 2013, 04:10 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 03, 2013Sale$67.195,854393,32747,058May 07, 2013, 07:17 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 30, 2013Award/Grant$23.2085819,91047,058May 07, 2013, 07:17 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 03, 2013Option/RSU Exercise$16.315,85495,45952,912May 07, 2013, 07:17 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMar 04, 2013Option/RSU Exercise$17.864,00071,44050,200Mar 06, 2013, 06:37 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMar 04, 2013Sale$60.184,000240,72446,200Mar 06, 2013, 06:37 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselFeb 27, 2013Sale$56.908,000455,18646,200Feb 28, 2013, 06:34 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselFeb 27, 2013Option/RSU Exercise$15.748,000125,88454,200Feb 28, 2013, 06:34 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 19, 2012Option/RSU Exercise$17.547,363129,14758,685Nov 19, 2012, 07:24 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 19, 2012Sale$48.507,363357,10651,322Nov 19, 2012, 07:24 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 11, 2012Option/RSU Exercise$14.3940,000575,60091,322May 15, 2012, 08:03 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 11, 2012Sale$37.9142,3091,604,02956,322May 15, 2012, 08:03 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 30, 2012Award/Grant$19.3598018,95940,631May 10, 2012, 02:43 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 30, 2012Award/Grant$19.3598018,95940,631May 10, 2012, 02:42 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 30, 2012Award/Grant$19.3598018,95940,631May 10, 2012, 02:41 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 01, 2011Sale$33.232608,64139,651Nov 02, 2011, 06:31 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselOct 31, 2011Award/Grant$13.232603,43939,911Nov 02, 2011, 06:31 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselJul 29, 2011Option/RSU Exercise$11.743,80044,61243,451Aug 02, 2011, 11:25 AM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselJul 29, 2011Sale$31.003,800117,80039,651Aug 02, 2011, 11:25 AM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselJul 22, 2011Sale$30.503,800115,90039,651Jul 25, 2011, 12:43 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselJul 22, 2011Option/RSU Exercise$11.743,80044,61243,451Jul 25, 2011, 12:43 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselJun 07, 2011Option/RSU Exercise-1,500-39,651Jun 09, 2011, 06:02 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 31, 2011Option/RSU Exercise$11.743,80044,61241,951Jun 02, 2011, 05:05 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 31, 2011Sale$28.503,800108,30038,151Jun 02, 2011, 05:05 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 26, 2011Sale$27.503,800104,50038,151May 31, 2011, 02:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 26, 2011Option/RSU Exercise$11.743,80044,61241,951May 31, 2011, 02:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 20, 2011Option/RSU Exercise-1,750-38,151May 24, 2011, 05:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 29, 2011Award/Grant$11.641,53017,80529,431May 04, 2011, 04:00 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 02, 2011Sale$27.091,53041,45227,901May 04, 2011, 04:00 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 13, 2011Option/RSU Exercise$11.743,80044,61231,701Apr 15, 2011, 04:58 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 13, 2011Sale$26.503,800100,70027,901Apr 15, 2011, 04:58 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMar 09, 2011Option/RSU Exercise$11.746,00070,44033,901Mar 11, 2011, 05:02 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMar 09, 2011Sale$24.496,000146,96627,901Mar 11, 2011, 05:02 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 24, 2010Option/RSU Exercise$11.745,00058,70032,901Nov 24, 2010, 06:16 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 24, 2010Sale$27.505,000137,50327,901Nov 24, 2010, 06:16 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 04, 2010Sale$25.8310,371267,92128,272Nov 05, 2010, 06:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselOct 29, 2010Award/Grant$11.643714,31728,272Nov 05, 2010, 06:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 04, 2010Option/RSU Exercise$11.7410,000117,40038,272Nov 05, 2010, 06:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselOct 29, 2010Award/Grant$11.643714,31728,272Nov 05, 2010, 04:20 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 04, 2010Option/RSU Exercise$11.7410,000117,40038,272Nov 05, 2010, 04:20 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 04, 2010Sale$25.8310,371267,92128,272Nov 05, 2010, 04:20 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselAug 20, 2010Option/RSU Exercise$11.7410,000117,40043,558Aug 24, 2010, 01:11 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselAug 20, 2010Sale$20.5715,657322,04933,558Aug 24, 2010, 01:11 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe